HRP20200763T1 - Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21 - Google Patents

Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21 Download PDF

Info

Publication number
HRP20200763T1
HRP20200763T1 HRP20200763TT HRP20200763T HRP20200763T1 HR P20200763 T1 HRP20200763 T1 HR P20200763T1 HR P20200763T T HRP20200763T T HR P20200763TT HR P20200763 T HRP20200763 T HR P20200763T HR P20200763 T1 HRP20200763 T1 HR P20200763T1
Authority
HR
Croatia
Prior art keywords
glp
inhibitor
function
agonist
intended
Prior art date
Application number
HRP20200763TT
Other languages
English (en)
Croatian (hr)
Inventor
Ken COPPIETERS
Matthias Von Herrath
Tamar BOURSALIAN
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP15720982.6A external-priority patent/EP3139948B1/en
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HRP20200763T1 publication Critical patent/HRP20200763T1/hr

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HRP20200763TT 2014-05-07 2020-05-11 Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21 HRP20200763T1 (hr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461989841P 2014-05-07 2014-05-07
EP14169596 2014-05-23
EP14189732 2014-10-21
EP15720982.6A EP3139948B1 (en) 2014-05-07 2015-05-05 Treatment of diabetes type 1 using glp-1 and anti-il-21
PCT/EP2015/059811 WO2015169789A1 (en) 2014-05-07 2015-05-05 Treatment of diabetes type 1 using glp-1 and anti-il-21

Publications (1)

Publication Number Publication Date
HRP20200763T1 true HRP20200763T1 (hr) 2020-07-24

Family

ID=70609983

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200763TT HRP20200763T1 (hr) 2014-05-07 2020-05-11 Liječenje dijabetesa tip 1 uz pomoć glp-1 i protutijela protiv il-21

Country Status (6)

Country Link
JP (1) JP6824373B2 (da)
DK (1) DK3139948T3 (da)
ES (1) ES2791879T3 (da)
HR (1) HRP20200763T1 (da)
HU (1) HUE048860T2 (da)
PT (1) PT3139948T (da)

Also Published As

Publication number Publication date
JP6824373B2 (ja) 2021-02-03
JP2020073501A (ja) 2020-05-14
PT3139948T (pt) 2020-05-22
ES2791879T3 (es) 2020-11-06
HUE048860T2 (hu) 2020-09-28
DK3139948T3 (da) 2020-05-25

Similar Documents

Publication Publication Date Title
HRP20201353T1 (hr) Agonisti glukagonskog receptora
JP2016512213A5 (da)
HRP20170905T1 (hr) Antikancerogeni fuzijski protein
JP2017532313A5 (da)
JP2018537415A5 (da)
PE20170954A1 (es) Compuestos co-agonistas de gip y glp-1
JP2017529067A5 (da)
HRP20220865T1 (hr) T stanični receptori
JP2015509091A5 (da)
JP2016536322A5 (da)
JP2016529229A5 (da)
HRP20220400T1 (hr) Imunoglobulinske varijabilne domene
NZ764889A (en) Composition for treating diabetes mellitus comprising insulin and a glp-1/glucagon dual agonist
PE20150648A1 (es) Proteinas de fusion para el tratamiento de un sindrome metabolico
AR065506A1 (es) Anticuerpos antagonistas ox40 y su uso en el tratamiento de enfermedades
JP2016500673A5 (da)
WO2016105545A3 (en) Insulin analogues with enhanced stabilized and reduced mitogenicity
CL2007001835A1 (es) Metodos para la preparacion de peptidos insulinotropicos, particularmente el peptido similar a glucagon 1 (glp-1) y los homologos del mismo, utilizando procesos en fase solida y en solucion; fragmento peptidico util en la preparacion del peptido insu
PE20220938A1 (es) Compuestos agonistas de gipr
WO2016057529A3 (en) Biphasic single-chain insulin analogues
JP2017536337A5 (da)
HRP20231118T1 (hr) Sintetizirani polipeptidi koji vežu transferinske receptore
HRP20150664T1 (hr) Antikancerogeni fuzijski protein
PE20130397A1 (es) Composicion farmaceutica combinada y metodos para el tratamiento de las enfermedades o condiciones funcionales del tracto gastrointestinal
PE20161221A1 (es) Anticuerpos de il-21